News for Genscript Biotech Corporation (GNNSF)

PISCATAWAY, N.J., Feb. 18, 2025 /PRNewswire/ -- GenScript Biotech Corp, a global leader in life sciences R&D and manufacturing services, today announced that it is committing to aggressive carbon emission reduction targets. These targets have been verified by the Science Based Targets initiative (SBTi), aligning closely with the 1.5°C warming pathway outlined in the Paris Agreement. This certification highlights GenScript's steadfast commitment to combating global climate change and marks an important milestone in the company's sustainability journey, guiding the company and its stakeholders, towards a low-carbon future.

**media[515645]**

Invited Speaker at 2025 GenScript Biotech Global Forum MIRAMAR, Fla., Jan. 15, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (”œHCWB” or ”œHCW Biologics”

PISCATAWAY, N.J., Jan. 14, 2025 /PRNewswire/ -- GenScript Biotech Corporation has unveiled an innovation in shipping packaging, propelling GenScript towards achieving their ambitious sustainability goals. The new packaging replaces plastic with 100% recyclable paper materials, reducing waste by 82% and lowering annual carbon emissions by 5.14 tons, equivalent to the CO2 absorbed by ~250 trees.

PISCATAWAY, N.J., Jan. 8, 2025 /PRNewswire/ -- GenScript Biotech Corporation, a global leader in life sciences research and manufacturing services, has officially joined the Pharmaceutical Supply Chain Initiative (PSCI) as a Supplier Partner. This milestone marks significant progress in GenScript's journey of fulfilling its social responsibility and advancing sustainable development, while underscoring the company's commitment to building a healthier, greener, and more ethical industry ecosystem.

PISCATAWAY, N.J., Nov. 11, 2024 /PRNewswire/ -- GenScript Biotech Corporation ('GenScript'), a global leader in life sciences services and products, has announced the establishment of new operations site and logistics center in Sydney, Australia. This strategic expansion represents a significant milestone in GenScript's continued commitment to supporting the rapid growth of the biotechnology sector in Australia. It also underscores the company's determination to strengthen GenScript's presence in the Asia-Pacific region and globally, advancing innovative solutions that address the evolving needs of the industry.

Pyrogen testing industry is projected to witness a CAGR of 9.1% during the period 2024-2032. This growth can be attributed to the growing investment in...

PISCATAWAY, N.J., Oct. 11, 2024 /PRNewswire/ -- GenScript Biotech Corporation has recently been upgraded to an A rating in its Environmental, Social, and Governance (ESG) score by MSCI, a globally recognized rating agency. This upgrade reflects GenScript's unwavering commitment to integrating sustainability, environmental responsibility, and social values into its business strategy.

Revenue: Increased by 43.5% to approximately USD 561.4 million.Adjusted Net Loss: Narrowed to about USD 69 million.Life Science Group Revenue: USD 217.7 millio

PISCATAWAY, N.J., Sept. 12, 2024 /PRNewswire/ -- GenScript Biotech Corporation ('GenScript'), a global leader in life sciences products and services, announced the appointment of Dr. Ross Allen Grossman as a Non-Executive Director and Dr. Alphonse Galdes as an Independent Non-Executive Director. These appointments not only further diversify the Group's Board but also highlight GenScript's commitment to building an international, diverse, and highly specialized corporate governance team. With the addition of these two directors, the company is better positioned to meet the challenges of a complex global landscape and governance requirements.

The Global Genetic Engineering Market Size was Valued at USD 1.35 Billion in 2023 and the Worldwide Genetic Engineering Market Size is Expected to Reach...

According to Research by SNS Insider, Growing Demand for Gene Editing Technologies, Substantial investments from governments and private entities in...

Visiongain has published a new report entitled Synthetic Biology Market Report 2024-2034: Forecasts by Product (Oligonucleotides & Synthetic DNA,...

Westford, USA, July 09, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the Global Synthetic Biology Market will attain a value of USD 87.27 Billion by...

DNA Synthesis industry is projected to witness a CAGR of 19.5% during the period 2024-2032. This growth can be owing to rapid technology advancements in...

The Global Cancer Profiling Market Size was valued at USD 9.65 Billion in 2022 and the Worldwide Cancer Profiling Market Size is expected to reach USD...

Marketresearch.biz highlights that the growth of gene editing market is driven by increased genetically modified crop production and rising demand for...

CRISPR/CAS 9 technology market revenue growth is due to increasing support from governments and rising private funding ...

/PRNewswire/ -- The "Biomanufacturing Viral Detection and Quantification Market - A Global and Regional Analysis: Focus on Offering Type, Technology,...